| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 11/24/2010 | CN101892172A Bare-glass fly arthrobacter strain and method for producing feeding proteins by using bare-glass fly arthrobacter strain to decompose gossypol |
| 11/24/2010 | CN101892168A Pichiapastoris expression strain for recombinant duck interleukin 2 and construction method and application thereof |
| 11/24/2010 | CN101892166A Candida parapsilosis strain and method for applying same in producing feed proteins by degrading gossypol |
| 11/24/2010 | CN101891816A Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof |
| 11/24/2010 | CN101891815A CK19 monoclonal antibody, and preparation method and application thereof |
| 11/24/2010 | CN101890046A Composition with heart rate reducing properties |
| 11/23/2010 | US7838648 Purified SR-p70 protein |
| 11/23/2010 | US7838640 Method of producing cell extract for cell-free protein synthesis |
| 11/23/2010 | US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838636 for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides; for genetic diseases such as muscular dystrophy and cystic fibrosis |
| 11/23/2010 | US7838635 CD16A binding proteins and use for the treatment of immune disorders |
| 11/23/2010 | US7838505 using hybrid Hepatocyte Growth Factor (HGF) construct for prevention and treatment of ischemic and liver disorders |
| 11/23/2010 | US7838278 Compositions and methods for manipulating carbon flux in cells |
| 11/23/2010 | US7838276 Carbohydrate utilization-related and multidrug transporter nucleic acids and polypeptides; producing a polypeptide by culturing a microbial cell that has beta-galactosidase activity; Lactobacillus acidophilus |
| 11/23/2010 | US7838274 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 11/23/2010 | US7838265 Compositions of aminoacyl-tRNA synthetase and uses thereof |
| 11/23/2010 | US7838254 G protein-coupled receptor (GPCR); conditions modulated by stimulation of NPY Y2 receptor (Y2R) including bone-related conditions, metabolic disorders, angiogenesis-related conditions, ischemia-related conditions, convulsive disorders, malabsorptive disorders, cancers, and inflammatory disorders |
| 11/23/2010 | US7838253 Using cold and menthol-sensitive receptor (CMR1) polypeptide as diagnostic tool in identifying modulators for treatment of pain and cold sensitivity |
| 11/23/2010 | US7838251 Nuclear matrix protein CC2 specfic immunoglobulin for use as evaluative tool in diagnosis of cell proliferative disorders of colon |
| 11/23/2010 | US7838247 determination of the Alzheimer Related Membrane Protein (ARMP) gene on chromosome 14 and a related gene, E5-1, on chromosome 1; diagnosing Alzheimer's disease |
| 11/23/2010 | US7838233 Method for the treatment of a sample containing biomolecules |
| 11/23/2010 | US7838010 inducing immunity against Streptococcus pyogenes by administering to an individual an effective amount of Group A streptococcal antigens |
| 11/23/2010 | US7837995 Anticancer agents; low dosage; side effect reduction |
| 11/23/2010 | US7837993 Methods and compositions for regeneration of aged skeletal muscle tissues |
| 11/23/2010 | US7837980 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 11/23/2010 | CA2343655C Interleukin 17-like receptor protein |
| 11/23/2010 | CA2263823C Mammalian artificial chromosomes |
| 11/23/2010 | CA2200610C Transgenic animals expressing human coagulation factor viii and von willebrand factor |
| 11/23/2010 | CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 11/23/2010 | CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof |
| 11/23/2010 | CA2132421C Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 11/18/2010 | WO2010132341A2 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
| 11/18/2010 | WO2010130804A1 Combinatorial engineering |
| 11/18/2010 | WO2010108182A3 Production of recombinant proteins in ciliates and uses thereof |
| 11/18/2010 | WO2010108153A3 Carrier immunoglobulins and uses thereof |
| 11/18/2010 | WO2010036979A3 Novel vectors for production of interferon |
| 11/18/2010 | US20100293665 Plants With Increased Yield (KO NUE) |
| 11/18/2010 | US20100293623 Rabbit nuclear cloning method and uses thereof |
| 11/18/2010 | US20100292456 Rna interference mediating small rna molecules |
| 11/18/2010 | US20100292441 Antibodies that specifically bind to GMAD |
| 11/18/2010 | US20100292312 Anti-dll4 antibodies and methods using same |
| 11/18/2010 | US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES |
| 11/18/2010 | US20100292151 Use of human cytokine receptor |
| 11/18/2010 | US20100292142 Novel neurotrophic factors |
| 11/18/2010 | US20100292136 Polymyxin derivatives and uses thereof |
| 11/18/2010 | US20100292130 Biological active proteins having increased in vivo and/or in vitro stability |
| 11/18/2010 | US20100291642 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor |
| 11/18/2010 | US20100291630 Method for producing a foaming agent |
| 11/18/2010 | US20100291629 Use of deleucocytation filters for defensin purification |
| 11/18/2010 | US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 11/18/2010 | US20100291627 Method for production of antibody |
| 11/18/2010 | US20100291626 Enhanced expression and stability regions |
| 11/18/2010 | US20100291625 Regulation of translation of heterologously expressed genes |
| 11/18/2010 | US20100291624 Compositions and methods for improved glycoprotein sialylation |
| 11/18/2010 | US20100291623 Process for producing alpha-glycosylated dipeptide and method of assaying alpha-glycosylated dipeptide |
| 11/18/2010 | US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 11/18/2010 | US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 11/18/2010 | US20100291559 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 11/18/2010 | US20100291150 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 11/18/2010 | US20100291141 Truncated l1 protein of human papillomavirus type 11 |
| 11/18/2010 | US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 11/18/2010 | US20100291133 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 11/18/2010 | US20100291131 Clostridial toxin netb |
| 11/18/2010 | US20100291130 Cloned genome of infectious hepatitis c virus strain hc-tn and uses thereof |
| 11/18/2010 | US20100291126 Protein showing enhanced expression in cancer cells |
| 11/18/2010 | US20100291121 Tumour-Specific Animal Proteins |
| 11/18/2010 | US20100291120 Peptides regulating the surface expression of the t cell receptor |
| 11/18/2010 | US20100291112 Recombinant, Single-Chain, Trivalent Tri-Specific or Bi-Specific Antibody Derivatives |
| 11/18/2010 | US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor |
| 11/18/2010 | US20100291096 Therapeutic peptides for the treatment of metatstatic cancer |
| 11/18/2010 | US20100291088 Il-18 binding proteins |
| 11/18/2010 | US20100291082 Antigen presenting cell targeted anti-viral vaccines |
| 11/18/2010 | US20100291072 Antibody variants with faster antigen association rates |
| 11/18/2010 | US20100291061 Process for making oligopeptides |
| 11/18/2010 | US20100291043 Il-12 immunotherapy for cancer |
| 11/18/2010 | US20100291001 Metalloproteinase-binding proteins |
| 11/18/2010 | CA2761578A1 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
| 11/18/2010 | CA2761277A1 Combinatorial engineering |
| 11/17/2010 | EP2251425A1 Process for producing protein A-like protein with use of Brevibacillus genus bacterium |
| 11/17/2010 | EP2251347A2 Methods for the production of ASLV reverse transcriptases composed of multiple subunits |
| 11/17/2010 | EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 11/17/2010 | EP2250279A2 Anti-ifnar1 antibodies with reduced fc ligand affinity |
| 11/17/2010 | EP2250278A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications |
| 11/17/2010 | EP2250257A1 Expression of catalase in trichoderma |
| 11/17/2010 | EP2249865A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 11/17/2010 | EP1590085B1 Novel supported catalyst systems |
| 11/17/2010 | EP1576182B1 Product quality enhancement in mammalian cell culture processes for protein production |
| 11/17/2010 | EP1565489B1 Internalizing antibodies specific for the RAAG10 cell surface target |
| 11/17/2010 | EP1420821B1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 11/17/2010 | EP1362093B1 Rapid production of monoclonal antibodies |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | EP1114827B1 Novel nucleic acid base pair |
| 11/17/2010 | CN1871359B Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 11/17/2010 | CN101889077A Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 11/17/2010 | CN101886109A Method for producing multifunctional antibacterial peptide |
| 11/17/2010 | CN101886107A Method for preparing pinctada martensii high F value oligopeptide by enzymatic method |
| 11/17/2010 | CN101886106A Method for extracting collagen peptide from fish scales |
| 11/17/2010 | CN101886105A Preparation of human glucagon like peptide (GLP-1) by mini-intein mediation |
| 11/17/2010 | CN101886095A Method for producing high-concentration D-lactic acid by adopting synchronous enzymolysis and fermentation on peanut meal and special culture medium thereof |